Google is asking buyers to pay more for Pixel hardware while making a familiar promise: the real upgrade is intelligence. At Made by Google 2026, Gemini—not a radical redesign—was positioned as the thread tying together phones, watches and a new tracker.

The event began with Google’s broadest Gemini pitch yet. The company introduced Rambler, a voice-input tool meant to understand rambling, imperfect speech, while Live Transcribe gained American Sign Language support through the Pixel camera. Sundar Pichai called the new devices “designed for Gemini Intelligence,” highlighting Rambler, Magic Capture and HiLight among the features he expects users to notice.Sundar Pichai (sundarpichai)¹

Then came the price test. The Pixel 11 starts at $899, up $100 from its predecessor, after Google dropped the 128GB option and made 256GB the entry-level storage tier. The Pixel 11 Pro likewise rises to $1,099, while the company emphasizes tougher materials, thinner camera hardware and durability improvements across the range.² Google’s wager is that assistants which translate, listen and act more proactively can make those increases feel earned.

Its hardware expansion also took direct aim at Apple. The $29 Pixel Tag joins Android’s Find Hub network, offering Bluetooth and Ultra Wideband tracking, a replaceable battery and the ability to ring the tag from a Pixel Watch. It is a slimmer oval rather than AirTag’s familiar round disc, though the basic proposition is the same: locate keys, bags and other easily misplaced items through a vast device network.³

Finally, Google pushed the Pixel Watch 5 toward proactive health monitoring. The $399 watch costs $50 more than last year’s model, despite modest hardware changes, but adds Breathing Emergency Detection and planned monthly blood-pressure and insulin-resistance trend summaries. Google stresses that the latter tools are not diagnostic; they are “check engine light”-type warnings built from longer-term patterns.⁴ That distinction matters: the company is selling AI as a guide, not a clinician—even as it makes the watch central to its health ambitions.